Free Trial

Iterum Therapeutics (ITRM) Insider Trading & Ownership

Iterum Therapeutics logo
$0.73 +0.01 (+0.69%)
As of 10:23 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Iterum Therapeutics (NASDAQ:ITRM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$10.80K
Number Of
Insiders Selling
(Last 12 Months)
0
Get ITRM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ITRM Insider Buying and Selling by Quarter

Iterum Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/8/2025Michael W DunneDirectorBuy15,000$0.72$10,800.00  
(Data available from 1/1/2013 forward)

ITRM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Iterum Therapeutics includes Brenton Karl Ahrens, Corey N Fishman, Michael W Dunne, and Sailaja Puttagunta. Learn more on insiders at ITRM.

2.40% of Iterum Therapeutics stock is owned by insiders. Learn more on ITRM's insider holdings.

The following insiders have purchased ITRM shares in the last 24 months: Corey N Fishman ($15,900.00), and Michael W Dunne ($86,400.00).

Insiders have purchased a total of 70,000 ITRM shares in the last 24 months for a total of $102,300.00 bought.

Iterum Therapeutics Key Executives

  • Mr. Corey N. Fishman (Age 59)
    President, CEO & Director
    Compensation: $1.3M
  • Ms. Judith M. Matthews (Age 54)
    Chief Financial Officer
    Compensation: $747.77k
  • Dr. Michael W. Dunne M.D. (Age 64)
    Strategic Advisor & Director
    Compensation: $115k
  • Dr. Sailaja Puttagunta M.D. (Age 55)
    Chief Medical Officer
    Compensation: $946.83k
  • Mr. Tom Loughman Ph.D.
    Senior Vice President of Technical Operations
  • Ms. Louise Barrett
    Senior Vice President of Legal Affairs & Secretary
  • Dr. Steven I. Aronin M.D.
    Senior VP & Head of Clinical Development


This page (NASDAQ:ITRM) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners